Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    Remdesivir for severe COVID-19: a clinical practice guideline

    Rochwerg, Bram; Agarwal, Arnav; Zeng, Linan; Leo, Yee-Sin; Appiah, John Adabie; Agoritsas, Thomas; Bartoszko, Jessica; Brignardello-Petersen, Romina; Ergan, Begum; Ge, Long; Geduld, Heike; Gershengorn, Hayley B; Manai, Hela; Huang, Minhua; Lamontagne, François; Kanda, Seema; Kawano-Dourado, Leticia; Kurian, Linda; Kwizera, Arthur; Murthy, Srinivas; Qadir, Nida; Siemieniuk, Reed; Silvestre, Maria Asuncion; Vandvik, Per Olav; Ye, Zhikang; Zeraatkar, Dena; Guyatt, Gordon.
    BMJ; 370 (), 2020
    Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...
    Betacoronavirus, Infecciones por Coronavirus/tratamiento farmacológico, Neumonía Viral/tratamiento farmacológico, Pandemias, Ensayos Clínicos Controlados Aleatorios como Asunto, Antivirales/uso terapéutico, Resultado del Tratamiento, Índice de Severidad de la Enfermedad
    Texto completo

    WHO Guidelines for pharmacological management of pandemic Influenza A(H1N1) 2009 and other influenza viruses: part I recommendations

    World Health Organization.
    The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...
    Subtipo H1N1 del Virus de la Influenza A, Pandemias, Oseltamivir/administración & dosificación, Gripe Humana/epidemiología, Grupos de Riesgo, Gripe Humana/tratamiento farmacológico, Antivirales/administración & dosificación, Zanamivir/administración & dosificación
    Texto completo

    WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses: part II review of evidence

    World Health Organization.
    This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....
    Pandemias, Subtipo H1N1 del Virus de la Influenza A, Gripe Humana/tratamiento farmacológico, Infecciones por Virus ARN/tratamiento farmacológico, Oseltamivir/administración & dosificación, Zanamivir/administración & dosificación, Amantadina/administración & dosificación, Rimantadina/administración & dosificación, Ribavirina/administración & dosificación, Antivirales/administración & dosificación
    Texto completo